Detalhe da pesquisa
1.
Accelerating Alzheimer's therapeutic development: The past and future of clinical trials.
Cell;
186(22): 4757-4772, 2023 10 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37848035
2.
APOE3 Christchurch Heterozygosity and Autosomal Dominant Alzheimer's Disease.
N Engl J Med;
390(23): 2156-2164, 2024 Jun 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38899694
3.
What Happens with the Circuit in Alzheimer's Disease in Mice and Humans?
Annu Rev Neurosci;
41: 277-297, 2018 07 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29986165
4.
Trial of Solanezumab in Preclinical Alzheimer's Disease.
N Engl J Med;
389(12): 1096-1107, 2023 Sep 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37458272
5.
Early Detection of Amyloid-Related Changes in Memory among Cognitively Unimpaired Older Adults with Daily Digital Testing.
Ann Neurol;
95(3): 507-517, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37991080
6.
Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease.
Ann Neurol;
95(2): 288-298, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37830926
7.
Relationships of Cognitive Measures with Cerebrospinal Fluid but Not Imaging Biomarkers of Alzheimer Disease Vary between Black and White Individuals.
Ann Neurol;
95(3): 495-506, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38038976
8.
Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease.
Brain;
147(6): 2158-2168, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38315899
9.
Amyloid-ß and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer's disease.
Proc Natl Acad Sci U S A;
119(15): e2113641119, 2022 04 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35380901
10.
Ultra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau.
Mol Psychiatry;
28(6): 2412-2422, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37020050
11.
Specific Association of Worry With Amyloid-ß But Not Tau in Cognitively Unimpaired Older Adults.
Am J Geriatr Psychiatry;
2024 May 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38763835
12.
Study Partner Report of Apathy in Older Adults is Associated with AD Biomarkers: Findings from the Harvard Aging Brain Study.
Am J Geriatr Psychiatry;
2024 Jan 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38443298
13.
Tau positron emission tomography in preclinical Alzheimer's disease.
Brain;
146(2): 700-711, 2023 02 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35962782
14.
Atrophy links lower novelty-related locus coeruleus connectivity to cognitive decline in preclinical AD.
Alzheimers Dement;
20(6): 3958-3971, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38676563
15.
Plasma Aß42/Aß40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease.
Alzheimers Dement;
20(2): 1214-1224, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37932961
16.
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial.
Alzheimers Dement;
20(6): 3827-3838, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38629508
17.
Novel avenues of tau research.
Alzheimers Dement;
20(3): 2240-2261, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38170841
18.
Lewy body dementia: Overcoming barriers and identifying solutions.
Alzheimers Dement;
20(3): 2298-2308, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38265159
19.
Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study.
Ann Neurol;
92(1): 11-22, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35471588
20.
Tau Mediates Synergistic Influence of Vascular Risk and Aß on Cognitive Decline.
Ann Neurol;
92(5): 745-755, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35880989